FNCH Finch Therapeutics Group Inc.

17.18
-0.33  -2%
Previous Close 17.51
Open 17.35
52 Week Low 15.265
52 Week High 22.5
Market Cap $809,958,006
Shares 47,145,402
Float 26,755,604
Enterprise Value $727,613,989
Volume 47,035
Av. Daily Volume 120,850
Stock charts supplied by TradingView

Upcoming Catalysts

Drug Stage Catalyst Date
FIN-211
Autism Spectrum Disorder
Phase 1
Phase 1
Premium membership is required to view catalyst dates, analyst ratings, earnings dates and cash burn data. Click here to unlock and sign up to a 14-day FREE TRIAL.

Drug Pipeline

Drug Stage Notes
CP101
Hepatitis B
Phase 1
Phase 1
Phase 1b trial to commence mid-2021.
FIN-524
Ulcerative Colitis
Phase 1
Phase 1
Phase 1 trial to commence 1H 2022.
CP101
Clostridioides difficile infection
Phase 3
Phase 3
Second Phase 3 trial to commence mid-2021.